Osiris Announces a Strategic Partnership with Stryker for Marketing Osiris' Viable Bone Matrix
December 22, 2014 at 16:31 PM EST
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing ...